Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Clevenbergh

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|June 12, 2003
Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptionsPhilippe Halfon, Jacques Durant, Philippe Clevenbergh, et al.
HIV Clinical Trials|March 15, 2005
Delay between first HIV-related symptoms and diagnosis of HIV infection in patients attending the internal medicine department of the Fondation Jeanne Ebori (FJE), Libreville, GabonMadeleine Okome-Nkoumou, Fleur Okome-Miame, Eric Kendjo, et al.
Scandinavian Journal of Infectious Diseases|March 20, 2010
Central nervous system tuberculomas in 23 patientsHorea Man, Pierre Sellier, Monique Boukobza, et al.
The Journal of Infectious Diseases|November 17, 2007
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosineAndrea De Luca, Simona Di Giambenedetto, Maria Paola Trotta, et al.
The Journal of Infectious Diseases|February 28, 2002
Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferationPierre-Marie Roger, Jean-Philippe Breittmayer, Jacques Durant, et al.
Antiviral Therapy|March 27, 2009
Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in AfricaStefaan F Van der Borght, Philippe Clevenbergh, Henk Rijckborst, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countriesPapa S Sow, Leander F Otieno, Emmanuel Bissagnene, et al.
AIDS Care|April 15, 2010
Long-term voluntary counseling and testing (VCT) uptake dynamics in a multicountry HIV workplace program in sub-Saharan AfricaStefaan F Van der Borght, Maarten F Schim van der Loeff, Philippe Clevenbergh, et al.
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
Frontiers in Pharmacology|February 5, 2024
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centersHélène Thirot, David Fage, Antonia Leonhardt, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|June 12, 2003
Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptionsPhilippe Halfon, Jacques Durant, Philippe Clevenbergh, et al.
HIV Clinical Trials|March 15, 2005
Delay between first HIV-related symptoms and diagnosis of HIV infection in patients attending the internal medicine department of the Fondation Jeanne Ebori (FJE), Libreville, GabonMadeleine Okome-Nkoumou, Fleur Okome-Miame, Eric Kendjo, et al.
Scandinavian Journal of Infectious Diseases|March 20, 2010
Central nervous system tuberculomas in 23 patientsHorea Man, Pierre Sellier, Monique Boukobza, et al.
The Journal of Infectious Diseases|November 17, 2007
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosineAndrea De Luca, Simona Di Giambenedetto, Maria Paola Trotta, et al.
The Journal of Infectious Diseases|February 28, 2002
Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferationPierre-Marie Roger, Jean-Philippe Breittmayer, Jacques Durant, et al.
Antiviral Therapy|March 27, 2009
Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in AfricaStefaan F Van der Borght, Philippe Clevenbergh, Henk Rijckborst, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countriesPapa S Sow, Leander F Otieno, Emmanuel Bissagnene, et al.
AIDS Care|April 15, 2010
Long-term voluntary counseling and testing (VCT) uptake dynamics in a multicountry HIV workplace program in sub-Saharan AfricaStefaan F Van der Borght, Maarten F Schim van der Loeff, Philippe Clevenbergh, et al.
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
Frontiers in Pharmacology|February 5, 2024
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centersHélène Thirot, David Fage, Antonia Leonhardt, et al.
Pageof 5